Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
08/2000
08/22/2000US6107086 Determined DNA sequences derived from a papillomavirus genome, their uses for in vitro diagnostic purposes and the production of antigenic compositions
08/22/2000US6107078 Ribozymes with optimized hybridizing arms, stems, and loops, tRNA embedded ribozymes and compositions thereof
08/22/2000US6107075 Human elastase IV
08/22/2000US6107073 Kinase capable of site-specific phosphorylation of IκBα
08/22/2000US6107071 Polynucleotide or complementary sequence which codes for a specific staphylococcus aureus amino acid sequence; for diagnosis of bacterial infections; screening of bactericides, bacteriostats, and antibiotics
08/22/2000US6107028 Prevention of viral replication or expression; insertion of a expression vector coding ribonucleic acid preferential proteolytic enzyme into cells infected with virus
08/22/2000US6107027 Supression of viral gene expression in cells; transducing cells with a adenovirus vector which codes a protein which has preferential proteolytic activity for ribonucleic acids
08/22/2000US6107021 Peptides for use as immunogens in mammals to produce polyclonal antibodies for the prevention of viral diseases
08/22/2000US6106868 Method for the treatment of hepatitis
08/22/2000US6106864 Pharmaceutical formulations containing darifenacin
08/22/2000US6106858 Loading active materials of liposomes by dissolving
08/22/2000US6106843 Process for the isolation of a nontoxinogenic vibrio cholerae strain and a process for preparing cholera vaccine from said vibrio cholerae strain
08/22/2000US6106842 Extraction of cell-bound protein from bordetella
08/22/2000US6106841 Delivery method for recombinant raccoon poxvirus
08/22/2000US6106830 Methods for the treatment of apoptosis-related diseases by batroxobin
08/22/2000US6106822 Hormone and growth factor phosphoglycokine mimetics from mycobacterium
08/22/2000CA2176973C Phenyl heterocycles as cyclooxygenase-2 inhibitors
08/22/2000CA2031199C Antibacterial and antimalarial peptides
08/22/2000CA2018801C Antiherpes peptide derivatives having a 1,4-dioxo c n-terminus
08/17/2000WO2000047756A1 Recombined porcine adenovirus based viral vaccines and vectors
08/17/2000WO2000047625A2 Humanized immunoglobulin reactive with b7 molecules and methods of treatment therewith
08/17/2000WO2000047611A2 Polymeric immunoglobulin receptor (pigr)-binding domains and methods of use therefor
08/17/2000WO2000047609A1 Cyclic peptides and aids vaccines
08/17/2000WO2000047602A1 33 human secreted proteins
08/17/2000WO2000047599A1 Novel nucleosides and oligonucleotide analogues
08/17/2000WO2000047591A1 Phosphoramidate, and mono-, di-, and tri-phosphate esters of (1r, cis)-4-(6-amino-9h-purin-9-yl)-2-cyclopentene-1-methanol as antiviral agents
08/17/2000WO2000047583A1 Cyclic substituted fused pyrrolocarbazoles and isoindolones
08/17/2000WO2000047581A1 Therapeutic nucleoside compound
08/17/2000WO2000047575A1 Pyrrole derivatives and cell death inhibitors
08/17/2000WO2000047574A1 Heteroaryl-substituted quinolin-2-one derivatives useful as anticancer agents
08/17/2000WO2000047562A1 Spirocyclic ketones and their use as tachykinin antagonists
08/17/2000WO2000047561A1 Non-nucleoside reverse transcriptase inhibitors
08/17/2000WO2000047554A2 INHIBITORS OF FACTOR Xa
08/17/2000WO2000047553A2 ALKENYL AND ALKYNYL COMPOUNDS AS INHIBITORS OF FACTOR Xa
08/17/2000WO2000047551A2 Inhibitors of aspartyl protease
08/17/2000WO2000047227A2 Mycobacterium tuberculosis, immunization
08/17/2000WO2000047224A2 Vaccine formulation comprising monoglycerides or fatty acids as adjuvant
08/17/2000WO2000047223A2 Viral vaccine
08/17/2000WO2000047222A2 Inactivated influenza virus vaccine for nasal or oral administration
08/17/2000WO2000047220A1 Controlling protein levels in eucaryotic organisms
08/17/2000WO2000047216A1 Immunogenic compositions for use as vaccines
08/17/2000WO2000047198A2 Use of substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds for treating hepatitis virus infections
08/17/2000WO2000047196A2 Use of statins for treating viral infections
08/17/2000WO2000047195A1 Stimulating neutrophil function to treat inflammatory bowel disease
08/17/2000WO2000047194A2 METHODS OF TREATING C1s-MEDIATED DISEASES AND CONDITIONS, AND COMPOUNDS AND COMPOSITIONS THEREFOR
08/17/2000WO2000047149A1 Gels formed by the interaction of poly(aldehyde) with various substances
08/17/2000WO2000047104A2 Antagonists of hmg1 for treating inflammatory conditions
08/17/2000WO2000031273A3 Process for oxidising terpenes
08/17/2000WO2000027857A3 Novel erythromycin derivatives, preparation method and use as medicines
08/17/2000WO2000014230A9 Novel molecules of the herpes virus-entry-mediator-related protein family and uses thereof
08/17/2000DE19956568A1 Verfahren und Medikament zur Hemmung der Expression eines vorgegebenen Gens Method and medicament for the inhibition of expression of a given gene
08/17/2000CA2367575A1 Stimulating neutrophil function to treat inflammatory bowel disease
08/17/2000CA2363088A1 Methods for treating viral infections
08/17/2000CA2362662A1 Phosphoramidate, and mono-, di-, and tri-phosphate esters of (1r, cis)-4-(6-amino-9h-purin-9-yl)-2-cyclopentene-1-methanol as antiviral agents
08/17/2000CA2362592A1 Humanized immunoglobulin reactive with b7 molecules and methods of treatment therewith
08/17/2000CA2362560A1 Controlling protein levels in eucaryotic organisms
08/17/2000CA2362525A1 Cyclic peptides and aids vaccines
08/17/2000CA2362375A1 Alkenyl and alkynyl compounds as inhibitors of factor xa
08/17/2000CA2362373A1 Polymeric immunoglobulin receptor (pigr)-binding domains and methods of use therefor
08/17/2000CA2362272A1 Spirocyclic ketones and their use as tachykinin antagonists
08/17/2000CA2361428A1 Inhibitors of factor xa
08/17/2000CA2361293A1 33 human secreted proteins
08/17/2000CA2360292A1 Immunogenic compositions for use as vaccines
08/17/2000CA2360233A1 Methods of treating c1s-mediated diseases and conditions, and compounds and compositions therefor
08/17/2000CA2359926A1 Antagonists of hmg1 for treating inflammatory conditions
08/17/2000CA2297441A1 Fusion proteins comprising carriers that can induce a dual immune response
08/16/2000EP1028118A1 Process for producing 3-cephem compounds
08/16/2000EP1027896A1 Broadly reactive opsonic antibodies that react with common staphyloccoccal antigens
08/16/2000EP1027895A2 Erysipelothrix rhusiopathiae antigens and vaccine compositions
08/16/2000EP1027893A2 Alginate containing medicament and implant for treating fibrosis
08/16/2000EP1027892A2 Azithromycin combination for emesis control in dogs
08/16/2000EP1027890A2 Homer a new target of treating psychiatric disorders
08/16/2000EP1027887A2 Matrix controlled release device
08/16/2000EP1027827A1 Disinfectant composition
08/16/2000EP1027362A1 2-halo-6-o-substituted ketolide derivatives
08/16/2000EP1027361A1 6,11-bridged erythromycin derivatives
08/16/2000EP1027360A2 3-descladinose 6-o-substituded erythromycin derivatives
08/16/2000EP1027359A2 Monocyclic l-nucleosides, analogs and uses thereof
08/16/2000EP1027353A1 Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
08/16/2000EP1027352A1 Carbapenem antibacterial compounds, compositions and methods of treatment
08/16/2000EP1027349A1 Tetrahydrofuran phosphate- and hydroxy esters, as prodrugs for the corresponding antifungal agent
08/16/2000EP1027332A1 Novel lactam metalloprotease inhibitors
08/16/2000EP1027078A1 IMMUNIZATION AGAINST $i(STREPTOCOCCUS PNEUMONIAE) USING CONJUGATED AND UNCONJUGATED PNEUMOCOCCAL POLYSACCHARIDE VACCINES
08/16/2000EP1027071A2 Encapsulated immunomodulators useful as vaccine adjuvants
08/16/2000EP1027070A1 Conjugate heat shock protein-binding peptides
08/16/2000EP1027062A1 Germicidal compositions for the treatment of animal infectious diseases of the hoof, comprising a copper salt, a quaternary ammonium compound and a peroxide
08/16/2000EP1027057A1 Treatment of female sexual dysfunction
08/16/2000EP1027036A2 Taste masked formulations
08/16/2000EP1026949A1 Outer membrane protein of ehrlichia canis and ehrlichia chaffeensis
08/16/2000EP1026945A1 Improved iodine antimicrobial compositions containing nonionic surfactants and halogen anions
08/16/2000EP0707481B1 L-2',3'-dideoxy nucleoside analogs as anti-hepatitis b (hbv) and anti-hiv agents
08/16/2000CN1263529A Carbocyclic nucleoside hemisulfate and its use in treating viral infectiosn
08/16/2000CN1263101A New derivative of erythromycin, its preparation method and medicinal application
08/16/2000CN1262958A Method for enhancing antigenicity of antigen being in vaccine preparation by using quillaira saponaria soponin adjuvant
08/16/2000CN1262928A Application of bilirubin and its derivative as preparation for resisting influenza virus A1 type
08/16/2000CN1262922A Cosmetic or skin-protecting composition containing at least one kind of alkynyl carbamate and polyol
08/16/2000CN1055500C DNA sequences which code for virulence characteristics of streptococcus suis and polypeptides and antibody derived therefrom
08/16/2000CN1055480C Substitution analogues of magainin peptides
08/16/2000CN1055477C Intermediate compound for synthesizing nucleoside derivative
08/16/2000CN1055474C Noval crystal type anhydrous 7-([1 alpha, 5 alpha, 6 alpha]=6-amino-3-azabicyclo [3,1,0] hexyl-3-group)-6-fluorine-1-(2,4-difluorophenyl
1 ... 1444 1445 1446 1447 1448 1449 1450 1451 1452 1453 1454 1455 1456 1457 1458 1459 1460 1461 1462 1463 1464 ... 1798